Niranjan Kanesa-thasan

Niranjan Kanesa-thasan is a declared insider of Icosavax, Inc., with filings sourced from SEC (Form 4). We count 17 filings; the first trade dates from 30 July 2021 and the latest from 19 February 2024.

Both buying and selling appear: 1 purchase worth €84k, against 7 sales worth €1.8M. On balance, insiders were net sellers of €1.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants and 6 option exercises. 2024 to date brings no purchases and 1 sale.

The latest filing, published on 20 February 2024, reports a transaction in Icosavax, Inc. The last insider purchase was made public on 2 August 2021, 1,909 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.